EBITDA for Align Technology (ALGN)
According to Align Technology's latest reported financial statements, the company's current EBITDA (TTM) is $806.86M USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
ALGN
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$806.86M
YoY change
-6.2%
5Y CAGR
+9.8%
Peak year (2021)
$1.09B
Cumulative EBITDA
$7.33B
EBITDA history chart for Align Technology (ALGN) from 1999 to 2025
EBITDA history table for Align Technology (ALGN) from 1999 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $765.87M | -6.2% | -$50.92M | ||
| 2024 | $816.80M | +2.2% | +$17.74M | ||
| 2023 | $799.05M | +2.5% | +$19.21M | ||
| 2022 | $779.84M | -28.1% | -$305.29M | ||
| 2021 | $1.09B | +125.7% | +$604.42M | ||
| 2020 | $480.71M | -19.0% | -$112.76M | ||
| 2019 | $593.47M | +13.8% | +$72.18M | ||
| 2018 | $521.29M | +33.2% | +$129.94M | ||
| 2017 | $391.35M | +43.4% | +$118.43M | ||
| 2016 | $272.92M | +32.1% | +$66.28M | ||
| 2015 | $206.64M | -2.3% | -$4.79M | ||
| 2014 | $211.43M | +18.7% | +$33.38M | ||
| 2013 | $178.05M | +27.2% | +$38.06M | ||
| 2012 | $139.99M | +29.8% | +$32.16M | ||
| 2011 | $107.84M | -11.2% | -$13.63M | ||
| 2010 | $121.47M | -683.9% | +$142.27M | ||
| 2009 | -$20.80M | -169.6% | -$50.70M | ||
| 2008 | $29.89M | -36.7% | -$17.35M | ||
| 2007 | $47.24M | -273.3% | +$74.50M | ||
| 2006 | -$27.27M | -311.4% | -$40.16M | ||
| 2005 | $12.90M | -47.3% | -$11.59M | ||
| 2004 | $24.49M | +1132.4% | +$22.50M | ||
| 2003 | $1.99M | -104.5% | +$45.73M | ||
| 2002 | -$43.74M | -38.4% | +$27.23M | ||
| 2001 | -$70.97M | -9.7% | +$7.63M | ||
| 2000 | -$78.60M | +455.6% | -$64.46M | ||
| 1999 | -$14.15M | — | — |
EBITDA values are taken from Align Technology's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual EBITDA for Align Technology (ALGN) came in at $765.87M – declined 6.2% year-over-year.
Align Technology EBITDA compound annual growth for the 2020–2025 (5 years) window is +9.8%, with the latest reading among the more recent periods of the dataset.
Between 2021 and 2025, Align Technology EBITDA declined 29.4%, falling from $1.09B to $765.87M.
The dataset's maximum EBITDA sits at $1.09B (2021); the minimum reading of -$78.60M dates to 2000.
Align Technology (ALGN) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $25.50B.
Align Technology EBITDA by Year
Align Technology EBITDA 2025: $765.87M
Align Technology EBITDA in 2025 was $765.87M, declined 6.2% below 2024.
Align Technology EBITDA 2024: $816.80M
Align Technology EBITDA in 2024 was $816.80M, edged up 2.2% from 2023.
Align Technology EBITDA 2023: $799.05M
Align Technology EBITDA in 2023 was $799.05M, edged up 2.5% from 2022.
Align Technology EBITDA 2022: $779.84M
Align Technology EBITDA in 2022 was $779.84M, declined 28.1% below 2021.
Align Technology EBITDA 2021: $1.09B
Align Technology EBITDA in 2021 was $1.09B.
See more financial history for Align Technology (ALGN).
Sector peers — EBITDA
Companies in the same sector as Align Technology, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Merck & Co. (MRK) | $29.32B | Healthcare |
| Eli Lilly (LLY) | $27.94B | Healthcare |
| UnitedHealth Group (UNH) | $23.06B | Healthcare |
| AstraZeneca (AZN) | $19.83B | Healthcare |
| AbbVie (ABBV) | $17.63B | Healthcare |
| Amgen (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Align Technology's EBITDA?
Latest reported EBITDA for Align Technology (ALGN) is $806.86M (period ending March 31, 2026).
How has Align Technology EBITDA changed year-over-year?
Align Technology (ALGN) EBITDA changed -6.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Align Technology EBITDA?
Align Technology (ALGN) EBITDA compound annual growth rate is +9.8% over the most recent 5 years available.
When did Align Technology EBITDA hit its highest annual value?
Align Technology EBITDA reached its highest annual value of $1.09B in 2021.
What was Align Technology EBITDA in 2024?
Align Technology (ALGN) EBITDA in 2024 was $816.80M.
What was Align Technology EBITDA in 2025?
Align Technology (ALGN) EBITDA in 2025 was $765.87M.
ALGN Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ALGN Overview
Company profile, financial tools, and key metrics
ALGN Revenue Counter
Earns $129.88 every second. See per minute, hour, and day.
ALGN Earnings Counter
Earns $13.63 per second net profit. See per minute, hour, and day.
ALGN Economic Scale
Exceeds Faroe Islands's GDP. Compare with world economies.
ALGN What If Invested
What if you had invested $1,000? See historical returns from any date.
ALGN How It Makes Money
Discover visual breakdown of $4.10B in revenue — where it comes from and where it goes.
ALGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ALGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ALGN Daily Price Character
Explosive · 49.8% historical win rate (green days). Streaks & record days.
ALGN Buybacks
1.80% TTM buyback yield. Shareholder yield & SBC comparison.